BCR and chronic myelogenous leukemia, BCR-ABL1 positive: InsRT-QBC targeting 40 regions on 14 mRNA transcripts was applied to K562 cells, a chronic myeloid leukemia (CML) cell line with known fusion gene, BCR-ABL64–66.